Examination of the effect of acute levodopa administration on the loudness dependence of auditory evoked potentials (LDAEP) in humans
- K. HitzAffiliated withDepartment of General Social Psychiatry, University of Zurich
- , K. HeekerenAffiliated withDepartment of General Social Psychiatry, University of Zurich
- , C. ObermannAffiliated withDepartment of General Social Psychiatry, University of Zurich
- , T. HuberAffiliated withInternal Medicine, Psychiatric University Hospital Zurich
- , G. JuckelAffiliated withDepartment of Psychiatry, Ruhr-University Bochum
- , W. KawohlAffiliated withDepartment of General Social Psychiatry, University of ZurichPsychiatric University Hospital Zurich Email author
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The loudness dependence of the auditory evoked potential (LDAEP) is considered a noninvasive in vivo marker of central serotonergic functioning in humans. Nevertheless, results of genetic association studies point towards a modulation of this biomarker by dopaminergic neurotransmission.
We examined the effect of dopaminergic modulation on the LDAEP using L-3,4-dihydroxyphenylalanine (levodopa)/benserazide (Madopar®) as a challenge agent in healthy volunteers.
A double-blind placebo-controlled challenge design was chosen. Forty-two healthy participants (21 females and 21 males) underwent two LDAEP measurements, following a baseline LDAEP measurement either placebo or levodopa (levodopa 200 mg/benserazide 50 mg) were given orally. Changes in the amplitude and dipole source activity of the N1/P2 intensities (60, 70, 80, 90, and 100 dB) were analyzed.
The participants of neither the levodopa nor the placebo group showed any significant LDAEP alterations compared to the baseline measurement. The test–retest reliability (Cronbachs Alpha) between baseline and intervention was 0.966 in the verum group and 0.759 in the placebo group, respectively.
The administration of levodopa showed no effect on the LDAEP. These findings are in line with other trials using dopamine receptor agonists.
KeywordsDopamine Loudness dependence auditory evoked potentials (LDAEP) Levodopa Primary auditory cortex Serotonin
- Examination of the effect of acute levodopa administration on the loudness dependence of auditory evoked potentials (LDAEP) in humans
Volume 221, Issue 3 , pp 389-396
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Loudness dependence auditory evoked potentials (LDAEP)
- Primary auditory cortex
- Industry Sectors
- Author Affiliations
- 1. Department of General Social Psychiatry, University of Zurich, Zurich, Switzerland
- 2. Internal Medicine, Psychiatric University Hospital Zurich, Zurich, Switzerland
- 3. Department of Psychiatry, Ruhr-University Bochum, Bochum, Germany
- 4. Psychiatric University Hospital Zurich, Militärstrasse 8, 8004, Zurich, Switzerland